Technical References ListTechnical References by Product - Each List In Reverse Chronological Order
Human Skin Tissue Equivalents:
EpiDerm™ Technical References
EpiDerm-201™ (Underdeveloped Tissue) Technical References
EpiDermFT™ Technical References
MelanoDerm™ Technical References
Melanoma Technical References
================
Other Human Tissue Equivalents:
EpiAirway™ Technical References
EpiOcular™ Technical References
EpiOral™/EpiGingival™ Technical References
EpiVaginal™ Technical References
================
Human Dendritic Cells:
Dendritic Cells Technical References
================
Technical References in Numerical Order - Oldest to Most Recent
(100 to 119)
(120 to 139)
( This Page )
(160 to 178)
(179 to 198)
(199 to 218)
(219 to 238)
(239 to 258)
(259 to 278)
(279 to 298)
(299 to 318)
(319 to 338)
(339 to 358)
(359 to 378)
(379 to 398)
(399 to 418)
(419 to 438)
(439 to 458)
(459 to 478)
(479 to 498)
(499 to 518)
(519 to 538)
(539 to 558)
(559 to 578)
(579 to 598)
(599 to 611)
140. |
|
MODULATION OF CYTOKINE MESSAGE IN THE EPIDERM IN VITRO SKIN MODEL FOLLOWING TREATMENT WITH CONTACT ALLERGENS AND SKIN IRRITANTS.
Sikorski, E.E., Gerberick, G.F., Limardi, L.C.
The Procter & Gamble Company, Cincinnati, OH.
The Toxicologist, 36 (1), 192, Soc. of Toxicol. (Reston, VA), Abstract #977, (1997).
|
141. |
|
DEMONSTRATING THE OCULAR SAFETY OF AN EYE COSMETIC PRODUCT USING ALTERNATIVES TO ANIMAL EYE IRRITATION TESTS.
Ghassemi1, A., Osborne1, R., Kohrman1, K. A., Roddy1, M. T., Harbell2, J.W., Kanengiser3, B.E.
1The Procter & Gamble Company, Hunt Valley, MD and Cincinnati, OH, 2Microbiological Associates, Inc. Rockville, MD, 3Clinical Research Laboratories, Inc., Piscataway, NJ. Sponsored by L.D. Lehman-McKeeman.
The Toxicologist, 36 (1), 42, Soc. of Toxicol. (Reston, VA), Abstract #221, (1997).
|
142. |
|
EPIOCULAR PREDICTION MODEL. A REPRODUCIBLE IN VITRO TISSUE CULTURE MEANS OF PREDICTING DRAIZE SCORES.
Kubilus, J., Sennott, H., Makwana, A., Klausner, M.
MatTek Corp., Ashland, MA.
The Toxicologist, 36 (1), 44, Soc. of Toxicol. (Reston, VA), Abstract #222, (1997).
|
143. |
|
PRESENCE OF HYDROCORTISONE DRAMATICALLY AFFECTS CYTOKINE PRODUCTION FOLLOWING UV IRRADIATION IN 3-DIMENSIONAL SKIN MODEL EPIDERM.
Sennott, H., Makwana, A., Kubilus, J., Klausner, M.
MatTek Corp., Ashland, MA.
J. Invest. Dermatol., 108(4), 665, Abstr. #765 (1997).
|
144. |
|
COMPARISON OF AN IN VITRO HUMAN SKIN EQUIVALENT MODEL TO NORMAL HUMAN SKIN FOR DERMATOLOGICAL RESEARCH.
Monteiro-Riviere1, N.A., Inman1, A.O., Qiao1, G., Snider2, T.H., Blank2, J.A., Hobson3, D.W.
1North Carolina State University, Cutaneous Pharmacology and Toxicology Center, Raleigh, NC, 2Battelle Memorial Research Institute, Columbus, OH, 3Dermatological Products of Texas, San Antonio, TX, USA.
Perspectives in Percutaneous Penetration, 5a, 65, (1997), also published in Microsc. Res. Tech., 37, 3, 172-9, (1997).
|
145. |
|
DEVELOPMENT OF AN IN VITRO MODEL FOR THE PREDICTION OF SKIN IRRITATION POTENTIAL.
Bernhofer, L.P., Seiberg, M., Martin, K.M.
Johnson & Johnson Consumer Products Worldwide, Skillman, NJ 08558.
Presented at 1997 Congress on In Vitro Biology, Washington, D.C. (1997).
|
146. |
|
EVALUATION OF THE EPIOCULAR TISSUE MODEL AS AN ALTERNATIVE TO THE DRAIZE EYE IRRITATION TEST.
1Stern, M., 2Klausner, M., 1Alvarado, R., 1Renskers, K., 1Dickens, M.
1Avon Products, Inc., Suffern, NY, 2MatTek Corp., Ashland, MA.
Toxicology In Vitro, 12, 455-461, (1998).
|
147. |
|
THE EPIOCULAR PREDICTION MODEL: AN ACCURATE, REPRODUCIBLE IN VITRO MEANS OF ASSESSING OCULAR IRRITANCY POTENTIAL.
Klausner, M., Sennott, H.A., Breyfogle, B., Makwana, A., Kubilus, J.
MatTek Corp., Ashland, MA.
Toxicology In Vitro, 12, (4), 455-461 (1998).
|
148. |
|
DEVELOPMENT OF AN IN VITRO METHOD FOR SKIN CORROSION TESTING.
Perkins, M.A., Osborne, R., Johnson, G.R.
The Procter & Gamble Co., Cincinnati, OH.
(1996). Fundam. Appl. Toxicol., 31, 9-18, (1996).
|
149. |
|
LOCALIZATION OF β-GLUCOCEREBROSIDASE ACTIVITY IN MAMMALIAN EPIDERMIS BY IN SITU ZYMOGRAPHY.
Kriehuber, E., Takagi, Y., Imokawa, G., Elias, P.M., Holleran, W.M.
Department of Dermatology, University of California, Dermatology Service, V.A. Medical Center, San Francisco, CA, Kao Corp., Tochigi, Japan.
J. Invest. Dermatol., 108(4), 594, Abstr. #337 (1997).
|
150. |
|
RECONSTITUTED 3-DIMENSIONAL HUMAN SKIN, A NEW IN VITRO MODEL FOR SKIN CARCINOGENESIS STUDY.
Zhao1, J.F., Zhan1, Y.J., Kubilus2, J., Jin1, X.H., Bickers1, D.R., Wang1, Z.Y.
1Department of Dermatology and Division of Environmental Science, Columbia University, New York, NY 10032, 2MatTek Corp., Ashland, MA 01721
J. Invest. Dermatol., 110(4), 525, Abstr. #319 (1998).
|
151. |
|
MATTEK'S TISSUE MODELS: NEW DEVELOPMENTS.
Klausner, M.
MatTek Corp., Ashland, MA 01721.
Presented at International Business Conference, "Latest In Vitro Testing Methods for Skin Care, Cosmetics, and Household Products," Washington, D.C., (1997).
|
152. |
|
VISUALIZATION OF IONTOPHORETIC TRANSPORT PATHS IN CULTURED AND ANIMAL SKIN MODELS.
Lee*, R.D., White*, H.S., Scott†, E.R.
*Department of Chemistry, University of Utah, Salt Lake City, UT, †Alza Corporation 8295 Central Avenue NE, Spring Lake Park, MN
J. Pharmaceutical Sciences, 85 (11), 1186, American Chemical Society and American Pharmaceutical Association (1996).
|
153. |
|
INITIAL RESULTS WITH EPI-201, A DEVELOPING IN VITRO MODEL OF HUMAN EPIDERMIS.
Klausner, M., Neal, P., Kubilus, J.
MatTek Corp., Ashland MA, USA.
J. Invest. Dermatol., 110(4), 558, Abstr. #513 (1998).
|
154. |
|
BIOCONVERSION OF TOCOPHERYL ACETATE TO TOCOPHEROL IN HUMAN SKIN ORGAN CULTURE MODELS.
Nabi, Z., Tavakkol, A., Soliman, N., Polefka, T.G.
Personal Care Products, Colgate-Palmolive Co., Piscataway, NJ, USA.
J. Invest. Dermatol., 110(4), 679, Abstr. #1239 (1998).
|
155. |
|
DEVELOPMENT OF A NEW IN VITRO TEST FOR DERMAL PHOTOTOXICITY USING A MODEL OF RECONSTITUTED HUMAN EPIDERMIS (EPIDERM).
Liebsch, M., Barrabas, C., Traue, D., Spielmann, H.
ZEBET, Berlin, Germany.
ALTEX, 14:165-174 (1997).
|
156. |
|
RECONSTRUCTED, DIFFERENTIATED AIRWAY EPITHELIAL CULTURES TO MODEL RESPIRATORY INFECTION.
Klausner1, M., Kubilus1, J., Ogle1, P., Adamou2, J.E., Langermann2, S.
1MatTek Corp., Ashland, MA 01721, 2MedImmune Incorporated, Gaithersburg, MD 20878.
Presented at the Lovelace Respiratory Research Institute symposium, "Validity of animal models of human respiratory diseases", Santa Fe, NM, October 1, (1998).
|
157. |
|
IN VITRO SCREENING TECHNIQUES IN DERMATOLOGY.
Majmudar, G., Smith, M.
Mary Kay Holding Corp., Dallas, TX.
Cosmetics & Toiletries Magazine, 113, 69-72, (1998)
|
158. |
|
TISSUE ABLATION WITH 100-fs AND 200-ps LASER PULSES.
Nishimura, N., Schaffer, E., Li, E., Mazur, E.
Department of Physics, Harvard University, Cambridge, MA 02138.
Conference Proceedings of IEEE Engineering, Medicine & Biology. (In press) (1999).
|
159. |
|
THE EYE IRRITATION TESTING OF THE ORGANIC SOLVENTS ON IN VITRO TEST USING 3-D CORNEAL MODEL.
Akaza, N., Kojima, H., Katada. T., Konishi, H.
Research Institute, Nippon Menard Cosmetic Co., Ltd.
Presented at 12th Annual Meeting of the Japanese Society for Alternatives to Animal Experiments, Sendai, Japan, November 18-19, (1998).
|
(100 to 119)
(120 to 139)
( This Page )
(160 to 178)
(179 to 198)
(199 to 218)
(219 to 238)
(239 to 258)
(259 to 278)
(279 to 298)
(299 to 318)
(319 to 338)
(339 to 358)
(359 to 378)
(379 to 398)
(399 to 418)
(419 to 438)
(439 to 458)
(459 to 478)
(479 to 498)
(499 to 518)
(519 to 538)
(539 to 558)
(559 to 578)
(579 to 598)
(599 to 611)
|
